Schedule
of Federal Statutory Tax Rate to The Effective Tax Rate
| | |
Year Ended December 31, 2025 | |
| | |
Amount | | |
Rate | |
| | |
| | |
| |
| U.S Federal statutory income rate | |
$ | (4,463 | ) | |
| 21.00 | % |
| State, net of federal tax benefit | |
| 9 | | |
| (0.04 | )% |
| Nontaxable or nondeductible items | |
| | | |
| | |
| Income/loss excluded from nontaxable entities | |
| 944 | | |
| (4.44 | )% |
| Permanent differences | |
| | | |
| | |
| Permanent differences | |
| | | |
| | |
| Meals and entertainment | |
| 7 | | |
| (0.04 | )% |
| Stock options | |
| 614 | | |
| (3.06 | )% |
| Equity award vesting | |
| 248 | | |
| (1.24 | )% |
| Modification of equity awards | |
| 2,194 | | |
| (10.95 | )% |
| Return-to-provision adjustments | |
| (44 | ) | |
| 0.22 | % |
| Other | |
| | | |
| | |
| Other | |
| | | |
| | |
| Valuation allowance | |
| 502 | | |
| (2.52 | )% |
| Effective rate | |
$ | 11 | | |
| (0.05 | )% |
A reconciliation of the federal
statutory tax rate to the effective tax rate (including Subchapter C-corporations) for the year ended December 31, 2024 and
2024 is as follows:
| | |
Year
Ended December 31, 2024 | |
| | |
Amount | | |
Rate | |
| | |
| | |
| |
| U.S Federal statutory
income rate | |
$ | 2,453 | | |
| 21.00 | % |
| State, net of federal tax
benefit | |
| (246 | ) | |
| (2.11 | )% |
| Income/loss excluded from
nontaxable entities | |
| (8,009 | ) | |
| (68.57 | )% |
| Permanent differences | |
| 641 | | |
| 5.49 | % |
| Return-to-provision adjustments | |
| 5 | | |
| 0.04 | % |
| Other | |
| 192 | | |
| 1.65 | % |
| Valuation
allowance | |
| 4,966 | | |
| 42.52 | % |
| Effective
rate | |
$ | 2 | | |
| 0.02 | % |
Significant components of the deferred
tax assets and liabilities (including Subchapter C-corporations) were as follows (in thousands):
Schedule
of Deferred Tax Assets and Liabilities
| | |
| | |
| |
| | |
Years Ended December 31, | |
| | |
2025 | | |
2024 | |
| | |
| | |
| |
| Deferred tax assets: | |
| | | |
| | |
| Start-up expenditures | |
$ | 4 | | |
$ | 13 | |
| Organizational expenditures | |
| 14 | | |
| | |
| Sec 174 – Research and development costs | |
| - | | |
| 3 | |
| Stock compensation | |
| 1,795 | | |
| 2,524 | |
| Lease liability | |
| 128 | | |
| 149 | |
| Property and equipment principally due to differences in depreciation | |
| 2 | | |
| 3 | |
| Bonus expense | |
| 14 | | |
| - | |
| Charitable contribution carryforwards | |
| 1 | | |
| 1 | |
| Impairment expense | |
| 53 | | |
| 11 | |
| Intangible Assets | |
| 51 | | |
| 38 | |
| Net operating loss carryforwards | |
| 4,890 | | |
| 3,781 | |
| Valuation allowance | |
| (6,625 | ) | |
| (6,124 | ) |
| Total deferred tax assets | |
$ | 327 | | |
$ | 399 | |
| | |
| | | |
| | |
| Deferred tax liabilities: | |
| | | |
| | |
| Right-of-use asset | |
$ | (115 | ) | |
$ | (135 | ) |
| Investment securities | |
| (212 | ) | |
| (264 | ) |
| Total deferred tax liabilities | |
$ | (327 | ) | |
$ | (399 | ) |
| | |
| | | |
| | |
| Net deferred tax assets/(liabilities) | |
$ | - | | |
$ | - | |
Net deferred tax assets and liabilities
were classified on the consolidated balance sheets as follows (in thousands):
| | |
| | |
| |
| | |
Years Ended December 31, | |
| | |
2025 | | |
2024 | |
| | |
| | |
| |
| Deferred tax assets | |
$ | 327 | | |
$ | 399 | |
| Deferred tax liabilities | |
| (327 | ) | |
| (399 | ) |
| Other noncurrent assets/(liabilities) | |
$ | - | | |
$ | - | |
|